Sign in

5am Venture Management, LLC

CIK:0001799883
Venture Capital
$1B AUM
29 holdings
San Francisco, CA, USA
Founded:2002
43 employees
Latest filing:Jun 30, 2025

5AM Ventures is a leading investment firm focused on funding and building next-generation life sciences companies.

Investment Strategy

Invests primarily in early-stage biopharmaceutical companies with a focus on Series A investments and small to mid-cap public and private biotech companies.

Top Buys
S
SKYESKYE BIOSCIENCE INC
+$25.7M
V
VORVOR BIOPHARMA INC
+$5.7M
E
EYPTEYEPOINT PHARMACEUTICALS INC
+$4.2M
M
MLTXMOONLAKE IMMUNOTHERAPEUTICS
+$2.3M
P
PHVSPHARVARIS N V
+$1.5M
Top Sells
T
TRDAENTRADA THERAPEUTICS INC
-$10.9M
E
ELVNENLIVEN THERAPEUTICS INC
-$10.5M
C
CAMPCAMP4 THERAPEUTICS CORP
-$7.5M
A
ANABANAPTYSBIO INC
-$6.7M
B
BHVNBIOHAVEN LTD
-$4.8M

Top Holdings

S
SKYESKYE BIOSCIENCE INC
+15.9%$41.4M
T
TRDAENTRADA THERAPEUTICS INC
+11.1%$29.0M
D
DNTHDIANTHUS THERAPEUTICS INC
+7.1%$18.3M
E
ELVNENLIVEN THERAPEUTICS INC
+6.0%$15.5M
P
PHVSPHARVARIS N V
+5.4%$14.0M

Equity Positions (29)

TickerSecurityWeightMarket ValueSharesAvg CostPriceChange (QoQ)
S
SKYE
SKYE BIOSCIENCE INC15.93%$41.4M9,913,168$8.06$4.18+$25.7M
T
TRDA
ENTRADA THERAPEUTICS INC11.13%$29.0M4,308,379$17.12$6.72-$10.9M
D
DNTH
DIANTHUS THERAPEUTICS INC7.05%$18.3M984,725$13.67$18.63-$297.3K
E
ELVN
ENLIVEN THERAPEUTICS INC5.96%$15.5M772,477$21.90$20.06-$10.5M
P
PHVS
PHARVARIS N V5.40%$14.0M797,600$23.67$17.60+$1.5M

Industry Allocation

PHARMACEUTICAL PREPARATIONS
+78.7%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+12.2%
SERVICES-MEDICAL LABORATORIES
+4.0%
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
+3.9%
LABORATORY ANALYTICAL INSTRUMENTS
+3.8%